Posts Tagged: $222 million

News

Strapped stem cell agency eyes tough options

Robert Klein addresses a meeting of two governing board committees of the California Institute for Regenerative Medicine. (Photo: David Jensen, California Stem Cell Report)

Facing the likelihood of a slow and withering death, the California stem cell agency is edging gingerly forward on a path of “cuts” and risky fund-raising in hopes that its research results will soon generate voter support for more billions of dollars. Two governing board committees of the $3 billion agency, formally known as the California Institute for Regenerative Medicine (CIRM), on Monday. Nov. 27,  recommended that the full board “entertain” the proposals at its Dec. 14 meeting.

Support for Capitol Weekly is Provided by: